SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000904454-20-000016
Filing Date
2020-01-09
Accepted
2020-01-09 16:41:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 13D/A FOR NAN FUNG RELATING TO THEIR INVESTMENT STEALTH BIO, SUBMITTED ON 1-9-20 s13da_010920-stealthbio.htm SC 13D/A 104185
  Complete submission text file 0000904454-20-000016.txt   105743
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Subject) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90943 | Film No.: 20518580
SIC: 2834 Pharmaceutical Preparations

Mailing Address 23RD FLOOR, NAN FUNG TOWER 88 CONNAUGHT ROAD CENTRAL CENTRAL K3 00000
Business Address 23RD FLOOR, NAN FUNG TOWER 88 CONNAUGHT ROAD CENTRAL CENTRAL K3 00000 852-2521-7417
Nan Fung Group Holdings Ltd (Filed by) CIK: 0001782539 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: SC 13D/A